Gwill York's most recent trade in Alto Neuroscience Inc. was a trade of 19,558 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 2, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Alto Neuroscience Inc. | Gwill York | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 19,558 | 19,558 | - | - | Stock Option (right to buy) | |
Alto Neuroscience Inc. | Gwill York | Director | 06 Feb 2024 | 53,196 | 0 | - | - | Series A Preferred Stock | ||
Alto Neuroscience Inc. | Gwill York | Director | 06 Feb 2024 | 23,917 | 23,917 | - | - | Common Stock | ||
Alto Neuroscience Inc. | Gwill York | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 30,574 | 30,574 | - | - | Stock Option (right to buy) | |
Alto Neuroscience Inc. | Gwill York | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 3,083 | 3,083 | - | - | Stock Option (right to buy) |